Ashley D. Reynolds, Ph.D. - Publications

Affiliations: 
Pharmacology and Experimental Neuroscience University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Parkinson's disease

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Gong N, Liu J, Reynolds AD, Gorantla S, Mosley RL, Gendelman HE. Brain ingress of regulatory T cells in a murine model of HIV-1 encephalitis. Journal of Neuroimmunology. 230: 33-41. PMID 20846730 DOI: 10.1016/J.Jneuroim.2010.08.014  0.514
2010 Kosloski LM, Ha DM, Hutter JA, Stone DK, Pichler MR, Reynolds AD, Gendelman HE, Mosley RL. Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases. Journal of Neurochemistry. 114: 1261-76. PMID 20524958 DOI: 10.1111/J.1471-4159.2010.06834.X  0.584
2010 Reynolds AD, Stone DK, Hutter JA, Benner EJ, Mosley RL, Gendelman HE. Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease. Journal of Immunology (Baltimore, Md. : 1950). 184: 2261-71. PMID 20118279 DOI: 10.4049/Jimmunol.0901852  0.691
2010 Reynolds AD, Stone DK, Mosley RL, Gendelman HE. Neuroprotective Activities of CD4+CD25+ Regulatory T Cells Neuroimmune Biology. 9: 197-210. DOI: 10.1016/S1567-7443(10)70022-3  0.56
2009 Huang X, Reynolds AD, Mosley RL, Gendelman HE. CD 4+ T cells in the pathobiology of neurodegenerative disorders. Journal of Neuroimmunology. 211: 3-15. PMID 19439368 DOI: 10.1016/J.Jneuroim.2009.04.006  0.602
2009 Reynolds AD, Stone DK, Mosley RL, Gendelman HE. Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells. Journal of Proteome Research. 8: 3497-511. PMID 19432400 DOI: 10.1021/Pr9001614  0.701
2009 Reynolds AD, Stone DK, Mosley RL, Gendelman HE. Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets. Journal of Immunology (Baltimore, Md. : 1950). 182: 4137-49. PMID 19299711 DOI: 10.4049/Jimmunol.0803982  0.707
2009 Liu J, Gong N, Huang X, Reynolds AD, Mosley RL, Gendelman HE. Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration. Journal of Immunology (Baltimore, Md. : 1950). 182: 3855-65. PMID 19265165 DOI: 10.4049/Jimmunol.0803330  0.581
2009 Stone DK, Reynolds AD, Mosley RL, Gendelman HE. Innate and adaptive immunity for the pathobiology of Parkinson's disease. Antioxidants & Redox Signaling. 11: 2151-66. PMID 19243239 DOI: 10.1089/Ars.2009.2460  0.608
2008 Banerjee R, Mosley RL, Reynolds AD, Dhar A, Jackson-Lewis V, Gordon PH, Przedborski S, Gendelman HE. Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. Plos One. 3: e2740. PMID 18648532 DOI: 10.1371/Journal.Pone.0002740  0.571
2008 Reynolds AD, Kadiu I, Garg SK, Glanzer JG, Nordgren T, Ciborowski P, Banerjee R, Gendelman HE. Nitrated alpha-synuclein and microglial neuroregulatory activities. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 3: 59-74. PMID 18202920 DOI: 10.1007/S11481-008-9100-Z  0.711
2008 Benner EJ, Banerjee R, Reynolds AD, Sherman S, Pisarev VM, Tsiperson V, Nemachek C, Ciborowski P, Przedborski S, Mosley RL, Gendelman HE. Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. Plos One. 3: e1376. PMID 18167537 DOI: 10.1371/Journal.Pone.0001376  0.699
2008 Reynolds AD, Glanzer JG, Kadiu I, Ricardo-Dukelow M, Chaudhuri A, Ciborowski P, Cerny R, Gelman B, Thomas MP, Mosley RL, Gendelman HE. Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease. Journal of Neurochemistry. 104: 1504-25. PMID 18036154 DOI: 10.1111/J.1471-4159.2007.05087.X  0.713
2008 Mosley RL, Reynolds A, Stone DK, Gendelman HE. Parkinson's disease and amyotrophic lateral sclerosis Neuroimmune Pharmacology. 641-659. DOI: 10.1007/978-0-387-72573-4_44  0.47
2007 Batrakova EV, Li S, Reynolds AD, Mosley RL, Bronich TK, Kabanov AV, Gendelman HE. A macrophage-nanozyme delivery system for Parkinson's disease. Bioconjugate Chemistry. 18: 1498-506. PMID 17760417 DOI: 10.1021/Bc700184B  0.602
2007 Reynolds A, Laurie C, Mosley RL, Gendelman HE. Oxidative stress and the pathogenesis of neurodegenerative disorders. International Review of Neurobiology. 82: 297-325. PMID 17678968 DOI: 10.1016/S0074-7742(07)82016-2  0.543
2007 Reynolds AD, Banerjee R, Liu J, Gendelman HE, Mosley RL. Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease. Journal of Leukocyte Biology. 82: 1083-94. PMID 17675560 DOI: 10.1189/Jlb.0507296  0.667
2007 Thomas MP, Chartrand K, Reynolds A, Vitvitsky V, Banerjee R, Gendelman HE. Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease. Journal of Neurochemistry. 100: 503-19. PMID 17241161 DOI: 10.1111/J.1471-4159.2006.04315.X  0.586
2007 Laurie C, Reynolds A, Coskun O, Bowman E, Gendelman HE, Mosley RL. CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Journal of Neuroimmunology. 183: 60-8. PMID 17196666 DOI: 10.1016/J.Jneuroim.2006.11.009  0.622
Show low-probability matches.